VISCOFAN FIBERCOLL-FLEX

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark VISCOFAN FIBERCOLL-FLEX was filed as Word mark on 07/28/2022 at the World Intellectual Property Organization.

Trademark Details Last update: July 17, 2023

Trademark form Word mark
File reference 1690740
Countries Brazil Canada China United Kingdom India Japan South Korea Mexico Poland Turkey United States of America (USA)
Base trademark EU No. 018736010, July 21, 2022
Application date July 28, 2022
Expiration date July 28, 2032

Trademark owner

C/ Berroa nº 15 4ª pl.
Polígono Industrial Berroa
ES

Trademark representatives

Calle Cedaceros, 1 E-28014 Madrid ES

goods and services

01 Biological materials or preparations for 3D printers, hydrogels for cell culture; hydrogels for cell growth; cell culture media (other than for medical or veterinary use); nutritional agents for processing living cells (other than for medical use); culture media for microbiology; reagents for scientific and medical research; synthetic peptides (not for pharmaceutical purposes); synthetic peptide derivatives (not for pharmaceutical purposes); cells (other than for medical, veterinary or pharmaceutical use); cells or tissues in hydrogels (other than for medical, veterinary or pharmaceutical use); biologically compatible polymers, specifically hydrogels used to produce polymer networks used in the manufacture of engineered living tissues for medical, scientific and non-scientific purposes; cell culture media for use in the biotechnological industry; cell culture media for use in non-medical research laboratories; biological preparations for use in cell culture, other than for medical and veterinary purposes; engineered living tissues and tissue arrays, namely, human and animal organs, connective tissue, epithelial tissue, muscular tissue and nervous tissue, and tissue arrays, for use in scientific and medical research; biologically compatible materials, specifically, hydrogels used to create polymeric networks used in the manufacture of living tissues; proteins in the form of raw materials for scientific and medical research
02 Inks of biological origin for printers; inks of biological origin for 3D printers
05 Hydrogels for medical, veterinary and pharmaceutical purposes for cellular biology applications; hydrogels for cell growth, cell growth and transplantation, assays based on cells, cancer cell research, regenerative medicine, stem cell growth and drug delivery; hydrogels for cell culture for medical, veterinary and pharmaceutical purposes; hydrogels for cell growth for medical, veterinary and pharmaceutical purposes; cell culture media; nutritional agents for processing living cells; synthetic peptides; synthetic peptide derivatives; cells for medical, veterinary and pharmaceutical use; cells or tissues in hydrogels for medical, veterinary or pharmaceutical use; pharmaceutical preparations for use in 3D bio-printing of tissues and organs; pharmaceutical preparations based on cellulose nanofibers for use in 3D bio-printing of tissues and organs; regenerative tissue [pharmaceutical preparations]; cells for medical use; allogeneic human tissue; living cells for medical use; implantation of living tissue with controlled tissue regeneration; implants containing living tissue; implantable living tissue materials for use in guided tissue regeneration; skin grafts; surgical implants formed by living tissue; surgical implants of living tissues derived from stem cells; transdermal patches for the creation of skin for prostheses and skin grafts; living tissue for transplants; engineered biological tissues and organs, namely, human and animal cardiovascular, pulmonary, digestive, hepatobiliary, urological, renal, endocrine, epithelial, muscular, and nervous tissues and organs, for medical purposes; biological molecules to assist in tissue engineering; hemostatic gel matrix preparations for wound treatment; natural biomaterials for the growth of bones, blood and tissues for medical purposes; pharmaceutical products for the regeneration of tissues, for the repair of tissues, for the treatment of tissues, whether human or animal; pharmaceutical preparations for the treatment of diseases of bones, cartilages, blood vessels, nerve cell degeneration, tendon and ligament degeneration, retinal degeneration, kidney degeneration; soft tissue degenerations, for diseases with abnormal cell growth; natural biomaterial for bone filling; natural biomaterial for cartilage filling; biological tissue cultures for medical use; biological tissue cultures for medical purposes; biological tissue grafts; bone and skin biological tissues impregnated with oxygen lines for tissue constructs applicable for increasing the cell survival in tissue intended for subsequent implants; gene therapy products, namely, genetically modified tissues for the transplant thereof; implantable stents containing living tissue to maintain the structure of the tissue; natural biomaterial for bone and tissue growth for medical purposes

Trademark history

Date Document number Area Entry
July 14, 2023 2023/28 Gaz MX Rejection
May 30, 2023 2023/22 Gaz TR Rejection
April 22, 2023 2023/17 Gaz US Rejection
April 10, 2023 2023/15 Gaz CN Rejection
February 22, 2023 2023/8 Gaz PL Rejection
January 18, 2023 2023/3 Gaz GB Rejection
July 28, 2022 2022/40 Gaz EM Registration

ID: 141690740